ENZIOR Trademark
ENZIOR is a USPTO trademark filed by NOVARTIS AG. Status: Registered.
Trademark Facts
| Mark | ENZIOR |
|---|---|
| Serial Number | 79379882 |
| Registration Number | 7292530 |
| Status | Registered |
| Filing Date | 2022-12-16 |
| Registration Date | 2024-01-30 |
| Mark Type | Word |
| Nice Classes | 005 (Pharmaceuticals) |
| Owner | NOVARTIS AG |
| Attorney of Record | Maury M. Tepper, III |
| Prosecution Events | 27 |
| Latest Event | OPNX on 2025-06-20 |
Goods & Services
Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the metabolic system, the endocrine system, the musculo skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma; all of the above excluding immunological diseases and disorders